Compare PACB & EAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACB | EAD |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.8M | 391.8M |
| IPO Year | 2010 | N/A |
| Metric | PACB | EAD |
|---|---|---|
| Price | $1.25 | $6.28 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $2.10 | N/A |
| AVG Volume (30 Days) | ★ 4.8M | 170.7K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.91% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $93,468,000.00 | N/A |
| Revenue This Year | $11.22 | N/A |
| Revenue Next Year | $12.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.04 | N/A |
| 52 Week Low | $0.85 | $5.89 |
| 52 Week High | $2.73 | $7.18 |
| Indicator | PACB | EAD |
|---|---|---|
| Relative Strength Index (RSI) | 34.36 | 22.10 |
| Support Level | $1.19 | N/A |
| Resistance Level | $1.37 | $6.91 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 6.82 | 3.19 |
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.